Literature DB >> 18584567

Effect of opium addiction on diabetes.

Laila Azod1, Maryam Rashidi, Mohammad Afkhami-Ardekani, Golchehr Kiani, Fariba Khoshkam.   

Abstract

BACKGROUND: Type 2 diabetes is a common disorder that is recognized as a major health problem in Iran. Diabetes is a major cause of morbidity, mortality, and economic burden to the society. Some people believe that smoking opium can reduce serum glucose and lipids in diabetes mellitus. This study was designed to compare blood glucose and lipids in opium addicts with non-addicts among patients with type 2 diabetes.
METHODS: In this case, control study subjects were chosen from type 2 diabetic patients. Twenty-three males with type 2 diabetes and addicted to opium were selected as the case group, and 46 patients with no addiction to opioid drugs were chosen as control group. Blood Sugar (BS), glycated hemoglobin (HbA1C), lipids and microalbumin in urine were measured in two groups.
RESULTS: Our results showed that the mean FBS and 2-hour post prandial were significantly different between two groups. (P = .04). No significant difference was observed in HbA1C, triglyceride, total cholesterol, LDL, and HDL between the two groups (P > .05).
CONCLUSIONS: Our finding showed that while opium might decrease blood glucose temporarily, it had no clear and long-lasting effects on blood glucose, as it had no significant effect on HbA1c.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18584567     DOI: 10.1080/00952990802122580

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  30 in total

Review 1.  Effects of opium consumption on cardiometabolic diseases.

Authors:  Farzad Masoudkabir; Nizal Sarrafzadegan; Mark J Eisenberg
Journal:  Nat Rev Cardiol       Date:  2013-10-22       Impact factor: 32.419

2.  Papaverine increases human serum albumin glycation.

Authors:  Alireza Ahmadzadeh
Journal:  J Biol Phys       Date:  2014-01-12       Impact factor: 1.365

3.  Effect of Severity of Opiate Use on Cardiometabolic Profile of Chronic Opiate Dependents of Western Rajasthan.

Authors:  Shailendera Dwivedi; Purvi Purohit; Naresh Nebhinani; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2018-06-06

4.  Relationship between Opium Abuse and Severity of Depression in Type 2 Diabetic Patients.

Authors:  Sepehrmanesh Zahra; Sarmast Hossein; Kord Valeshabad Ali
Journal:  Diabetes Metab J       Date:  2012-04-17       Impact factor: 5.376

5.  Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study.

Authors:  Mahdi Nalini; Masoud Khoshnia; Farin Kamangar; Maryam Sharafkhah; Hossein Poustchi; Akram Pourshams; Gholamreza Roshandel; Samad Gharavi; Mahdi Zahedi; Alireza Norouzi; Masoud Sotoudeh; Arash Nikmanesh; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh; Arash Etemadi
Journal:  Int J Epidemiol       Date:  2021-03-03       Impact factor: 7.196

6.  Is opium addiction a risk factor for ischemic heart disease and ischemic stroke?

Authors:  Mohammad Reza Rezvani; Kavian Ghandehari
Journal:  J Res Med Sci       Date:  2012-10       Impact factor: 1.852

7.  Nutritional status and eating habits of people who use drugs and/or are undergoing treatment for recovery: a narrative review.

Authors:  Nadine Mahboub; Rana Rizk; Mirey Karavetian; Nanne de Vries
Journal:  Nutr Rev       Date:  2021-05-12       Impact factor: 7.110

8.  Cholangiographic features in opium-addicted patients at a tertiary hospital in iran.

Authors:  Amir Houshang Mohammad Alizadeh; Esmaeal Shams Afzali; Azar Sanati; Anahita Shahnazi; Dariush Mirsattari; Mohammad Reza Zali
Journal:  Gastroenterol Res Pract       Date:  2012-10-15       Impact factor: 2.260

Review 9.  Coronary artery disease and its risk factors status in iran: a review.

Authors:  M Ebrahimi; S M R Kazemi-Bajestani; M Ghayour-Mobarhan; G A A Ferns
Journal:  Iran Red Crescent Med J       Date:  2011-09-15       Impact factor: 0.611

10.  Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter?

Authors:  Sedigheh Asgary; Nizal Sarrafzadegan; Gholam-Ali Naderi; Reza Rozbehani
Journal:  Lipids Health Dis       Date:  2008-11-03       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.